These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 30022148)
1. Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/GADD45B. Wang L; Zhang L; Hou Q; Zhu X; Chen Z; Liu Z Sci Rep; 2018 Jul; 8(1):10843. PubMed ID: 30022148 [TBL] [Abstract][Full Text] [Related]
2. Triptolide preserves glomerular barrier function via the inhibition of p53-mediated increase of GADD45B. Zhai X; Wang L; Xu C; Hou Q; Zhang L; Li Z; Qin W; Liu Z; Chen Z Arch Biochem Biophys; 2019 Aug; 671():210-217. PubMed ID: 31330131 [TBL] [Abstract][Full Text] [Related]
3. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. Chen ZH; Qin WS; Zeng CH; Zheng CX; Hong YM; Lu YZ; Li LS; Liu ZH Kidney Int; 2010 Jun; 77(11):974-88. PubMed ID: 20375980 [TBL] [Abstract][Full Text] [Related]
4. Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway. Wan Q; Liu Z; Yang M; Deng P; Tang N; Liu Y BMC Mol Cell Biol; 2020 Feb; 21(1):4. PubMed ID: 32013860 [TBL] [Abstract][Full Text] [Related]
5. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro. Zheng CX; Chen ZH; Zeng CH; Qin WS; Li LS; Liu ZH Kidney Int; 2008 Sep; 74(5):596-612. PubMed ID: 18509322 [TBL] [Abstract][Full Text] [Related]
6. GADD45B mediates podocyte injury in zebrafish by activating the ROS-GADD45B-p38 pathway. Chen Z; Wan X; Hou Q; Shi S; Wang L; Chen P; Zhu X; Zeng C; Qin W; Zhou W; Liu Z Cell Death Dis; 2016 Jan; 7(1):e2068. PubMed ID: 26794661 [TBL] [Abstract][Full Text] [Related]
7. Anti-Inflammatory and Neuroprotective Effects of Triptolide via the NF-κB Signaling Pathway in a Rat MCAO Model. Bai S; Hu Z; Yang Y; Yin Y; Li W; Wu L; Fang M Anat Rec (Hoboken); 2016 Feb; 299(2):256-66. PubMed ID: 26575184 [TBL] [Abstract][Full Text] [Related]
8. Suppression of the migration and invasion is mediated by triptolide in B16F10 mouse melanoma cells through the NF-kappaB-dependent pathway. Jao HY; Yu FS; Yu CS; Chang SJ; Liu KC; Liao CL; Ji BC; Bau DT; Chung JG Environ Toxicol; 2016 Dec; 31(12):1974-1984. PubMed ID: 26420756 [TBL] [Abstract][Full Text] [Related]
10. Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-κB pathway. Song C; Wang Y; Cui L; Yan F; Shen S BMC Complement Altern Med; 2019 Aug; 19(1):198. PubMed ID: 31375092 [TBL] [Abstract][Full Text] [Related]
11. Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway. Park B; Sung B; Yadav VR; Chaturvedi MM; Aggarwal BB Biochem Pharmacol; 2011 Nov; 82(9):1134-44. PubMed ID: 21820422 [TBL] [Abstract][Full Text] [Related]
12. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway. Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788 [TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells. Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088 [TBL] [Abstract][Full Text] [Related]
14. Triptolide alleviates hepatic ischemia/reperfusion injury by attenuating oxidative stress and inhibiting NF-κB activity in mice. Wu C; Wang P; Rao J; Wang Z; Zhang C; Lu L; Zhang F J Surg Res; 2011 Apr; 166(2):e205-13. PubMed ID: 21227469 [TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia. Gong Y; Xue B; Jiao J; Jing L; Wang X J Neurochem; 2008 Nov; 107(3):779-88. PubMed ID: 18761708 [TBL] [Abstract][Full Text] [Related]
16. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation. Lee KY; Park JS; Jee YK; Rosen GD Exp Mol Med; 2002 Dec; 34(6):462-8. PubMed ID: 12526088 [TBL] [Abstract][Full Text] [Related]
17. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684 [TBL] [Abstract][Full Text] [Related]
18. Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex. Kizelsztein P; Komarnytsky S; Raskin I J Neuroimmunol; 2009 Dec; 217(1-2):28-37. PubMed ID: 19796825 [TBL] [Abstract][Full Text] [Related]
19. Dual-function of triptriolide in podocytes injury: inhibiting of apoptosis and restoring of survival. Yang YQ; Liang J; Han XD; Tian RM; Liu XS; Mao W; Xu HT; Liu B; Xu P Biomed Pharmacother; 2019 Jan; 109():1932-1939. PubMed ID: 30551448 [TBL] [Abstract][Full Text] [Related]
20. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]